Plus Therapeutics (PSTV) Competitor Comparison
We are evaluating the key criteria listed to compare Plus Therapeutics (PSTV) against its competitors in the Biotechnology industry.
Market Capitalization
346 / 368Gross Profits
159 / 278Total Revenue
210 / 300EBITDA
65 / 337Free Cashflow
81 / 352Quick Ratio
325 / 357Earnings per Share
252 / 359Dividend yield
0 / 6Total Cash
322 / 358Performance 3 years
335 / 368Performance 5 years
338 / 368Performance 10 years
368 / 368Linearity 3 years
283 / 368Linearity 5 years
220 / 368Linearity 10 years
285 / 368Total Rank
345 / 368Dividend Rank
236 / 368Valuation Rank
321 / 368Piotroski Rank
201 / 368Muliplier Rank
179 / 368Linearity 5 years - PSTV ranking 220 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.